BLINCYTO 35/38.5 mcg
- Name: BLINCYTO
- Generic Name: Blinatumomab
- Strength: 35 mcg | 38.5 Single-Dose Vial
- Manufactured : Amgen Inc
Committed to quality: All medicines delivered with complete temperature integrity assurance.”Learn more about our temperature regulations.
Blincyto contains Blinatumomab is a bispecific CD19-directed CD3 T-cell engager. Blincyto uses are:
- B-cell precursor acute lymphoblastic leukemia in first or second complete remission with minimal residual disease greater than or equal 0.1%.
- Relapsed or refractory B-cell precursor ALL (Acute Lymphoblastic Leukemia).
Note: – Blincyto is an FDA approved drug.
- Assess patients with blinatumomab injection for signs and symptoms of neurological toxicities. Advise outpatients on Blinatumomab to contact their health specialist if they develop signs/symptoms of neurological toxicities.
- Monitor patients with Blincyto doses for signs and symptoms of infection and treat appropriately.
- Assess laboratory parameters (including, but not limited to, WBC count and absolute neutrophil count) during blinatumomab infusion. Interrupt this medication if prolonged neutropenia occurs.
- Monitor aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma-glutamyl transferase (GGT), and total blood bilirubin before the start of and while on Blincyto 35 mcg treatment.
- Assess patients who develop signs of pancreatitis. Management of pancreatitis may need either temporary interruption or discontinuation of Blincyto injection and dexamethasone.
- Healthcare professionals recommend not to have vaccination with live virus vaccines for at least before 2 weeks Blinatumomab 35 mcg treatment, during treatment, and until immune recovery following the last cycle of Blinatumomab.
What documents are required to import Blincyto?
Blincyto (Blinatumomab) injection can be imported by patients or government hospitals on behalf of patients. The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patient’s diagnostic reports.
- Patient’s ID proof (issued by the Government of the respective country).
How is the order confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from a doctor.
- Import permit if applicable.
Is Blincyto available worldwide?
Blincyto (Blinatumomab) injection is a prescription pharmaceutical drug that legally requires a medical prescription for dispensation.
Indian Pharma Network (IPN) facilitates the import of critical medications like Blincyto (Blinatumomab) globally, ensuring the named patient supply (NPS). IPN is the facilitator that provides essential support for:
- Availability of Blincyto (Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, and Sri Lanka).
- BLINCYTO Available in India (Noida, Delhi, Mumbai, Gurgaon, Lucknow, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc
- Determining Medicine Price.
- Sourcing genuine and reliable sources from the USA, Canada, Europe, and Australia.
- Ensuring 100% transparency.
Blincyto (Blinatumomab) injection can be made available to patients, doctors, and hospitals in various countries across the globe. The order will be confirmed only after receiving a valid prescription from the doctor and, if required, an import permit.
Indian Pharma Network (IPN) can facilitate the supply of Blincyto (prescription medicine) to locations worldwide while adhering to legal requirements (if applicable).
We assure quality and worldwide delivery as per the buyer’s specifications.
Indian Pharma Network is proficient in sourcing Blincyto (Blinatumomab) injection from around the world and has the capability to supply it. We offer global access to the best available treatment for our customers worldwide in countries like Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, and Sri Lanka.
Indian Pharma Network (IPN) is committed to dispensing any valid prescription promptly. All prescriptions are dispensed and verified by registered pharmacists and are dispatched only to the patient’s address. Your health and well-being are our top priorities
Indian Pharma Network helps you to connect with potential distributors, wholesalers, suppliers and dealers of Blincyto in India.
What is the Generic Name for the trade name drug Blincyto®?
Blinatumomab is the Generic Name for the trade name drug Blincyto®.
What is the Manufacturer’s Name of Blincyto®?
Blincyto® is manufactured by Amgen Inc.
Is Blincyto® approved by the FDA?
Yes. Blincyto® is approved by the FDA. Date of first approval: December 3, 2014.
What strengths and dosage forms are available for Blincyto®?
Blincyto® is supplied for injection: 35 mcg of lyophilized powder in a single-dose vial for reconstitution for intravenous use.
What are the most common side effects of Blincyto® Injections?
The most commonly reported side effects of Blincyto are pyrexia, nausea, infusion-related reactions, musculoskeletal pain, headache, infection, neutropenia, thrombocytopenia, anemia, and diarrhea.
What is the availability of Blincyto® near Medanta Hospital in Gurgaon?
Patients receiving treatment near Medanta Hospital can obtain Blincyto® through a patient-specific import pathway. With a valid oncologist’s prescription, the treatment can be arranged and delivered directly to the hospital in Gurgaon.
What is the availability of Blincyto® in Bangalore?
Blincyto® is not commercially marketed in Bangalore, but patients can still access it through regulated import provisions. Once prescribed by treating clinician, the medicine is sourced internationally and supplied to the treating hospital.
What is the availability of Blincyto® in Mumbai?
Patients in Mumbai can access Blincyto® via special access programs that allow import of approved international medicines. The treatment is delivered to the hospital where the patient is undergoing care.
I want to buy Blincyto® in Mumbai—how can I access it?
If you are looking to buy Blincyto® in Mumbai, the first step is consultation with your oncologist. Once prescribed, the medicine can be arranged from global sources under a compliant import process and delivered to your treating hospital.
I want to buy Blincyto® in Bangalore—what is the process?
Patients in Bangalore can access Blincyto® through a regulated pathway that enables the import of medicines for individual use. After prescription approval, the drug is procured internationally and supplied directly to the hospital for treatment.
Can I buy Blincyto® at major hospitals like Tata, Apollo, or Fortis?
Blincyto® can be accessed at leading hospitals such as Tata Memorial Centre, Apollo Hospitals, Fortis Healthcare, Max Healthcare, Manipal Hospitals, and Kokilaben Dhirubhai Ambani Hospital through the Named Patient Program (NPP) with a valid oncologist’s prescription. Indian Pharma Network assists with import and delivery to the treating hospital.
How does Blincyto Import in India work?
Blincyto Import in India is possible through the Named Patient Program. This means the medicine can be imported for a specific patient with a valid doctor’s prescription. Indian Pharma Network helps manage the complete process, including approvals and delivery, making sure the medicine reaches the patient safely and legally.
Who is a reliable Blincyto supplier in India?
Indian Pharma Network is a trusted Blincyto supplier in India, facilitating compliant access through global sourcing channels and structured documentation support for eligible patients under applicable regulatory provisions.
How much does Blincyto® Injection cost in India?
Blincyto® is not yet approved in India. However, patients in India can legally access it through the provision called the Named Patient Program (NPP). Blincyto prices may fluctuate over time because of market dynamics and regulatory changes. For the most transparent and latest Blincyto cost in India, please call/WhatsApp +91 98104 69557 or send an email to info@indianpharmanetwork.in.
Can Blincyto® Injections be available in SAARC countries?
Apart from Gulf countries, Blincyto® Injections can be accessed through import provisions like the Named Patient Program (NPP) in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Blincyto® Injections in these countries. We help provide legal access to this therapeutic drug through our reliable channels.
Is it safe to buy Blincyto® Injections online in India?
Yes, one can buy Blincyto in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not yet registered or available in their country. We can help facilitate the supply of Blincyto® Injections through legal channels.
Who is an authorized Blincyto importer in India?
Indian Pharma Network acts as Blincyto importer in India, assisting with Named Patient Import processes, regulatory documentation, and compliant international procurement for patients requiring this therapy.
In which countries is Blincyto approved?
Blincyto® has received regulatory approval across several major global markets, including the United States, Canada, the European Union, China, Japan, Singapore, and South Korea. In addition, regulatory evaluations are ongoing in regions such as Taiwan and Hong Kong.
Can I buy Blincyto® from Europe, the USA, or other countries?
Blincyto® is approved and available in regions like Europe, the United States, Canada, Japan, Singapore, and China, but patients in India cannot directly purchase it from abroad. It can be legally accessed through the Named Patient Program (NPP) with a valid prescription. Indian Pharma Network assists with compliant sourcing and delivery to the treating hospital.
What are the storage conditions of Blincyto® Injections?
Store Blincyto and IV Solution Stabilizer vials in the original package refrigerated at 2°C to 8°C (36°F to 46°F) and protect from light until time of use. Do not freeze.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.